482 related articles for article (PubMed ID: 17428293)
41. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.
Watanabe T; Sagisaka H; Arakawa S; Shibaya Y; Watanabe M; Igarashi I; Tanaka K; Totsuka S; Takasaki W; Manabe S
J Toxicol Sci; 2003 Dec; 28(5):455-69. PubMed ID: 14746349
[TBL] [Abstract][Full Text] [Related]
42. Stereospecific effects of R-lipoic acid on buthionine sulfoximine-induced cataract formation in newborn rats.
Maitra I; Serbinova E; Tritschler HJ; Packer L
Biochem Biophys Res Commun; 1996 Apr; 221(2):422-9. PubMed ID: 8619871
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
44. Gene expression of energy and protein metabolism in hearts of hypertensive nitric oxide- or GSH-depleted mice.
Chon H; Bluyssen HA; Holstege FC; Koomans HA; Joles JA; Braam B
Eur J Pharmacol; 2005 Apr; 513(1-2):21-33. PubMed ID: 15878706
[TBL] [Abstract][Full Text] [Related]
45. Cytochrome P450 2E1 potentiates ethanol induction of hypoxia and HIF-1α in vivo.
Wang X; Wu D; Yang L; Gan L; Cederbaum AI
Free Radic Biol Med; 2013 Oct; 63():175-86. PubMed ID: 23669278
[TBL] [Abstract][Full Text] [Related]
46. Metabolic basis of ethanol-induced hepatic and pancreatic injury in hepatic alcohol dehydrogenase deficient deer mice.
Bhopale KK; Wu H; Boor PJ; Popov VL; Ansari GA; Kaphalia BS
Alcohol; 2006 Jul; 39(3):179-88. PubMed ID: 17127137
[TBL] [Abstract][Full Text] [Related]
47. Hepatotoxicity of eugenol and related compounds in mice depleted of glutathione: structural requirements for toxic potency.
Mizutani T; Satoh K; Nomura H
Res Commun Chem Pathol Pharmacol; 1991 Jul; 73(1):87-95. PubMed ID: 1882130
[TBL] [Abstract][Full Text] [Related]
48. The effect of buthionine sulfoximine on the glutathione level in goldfish tissues.
Lushchak VI; Hermes-Lima M
Ukr Biokhim Zh (1999); 2005; 77(3):35-8. PubMed ID: 16566126
[TBL] [Abstract][Full Text] [Related]
49. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration.
Donohue TM; Zetterman RK; Zhang-Gouillon ZQ; French SW
Hepatology; 1998 Aug; 28(2):486-91. PubMed ID: 9696015
[TBL] [Abstract][Full Text] [Related]
50. Increased lipid peroxidation in the liver and kidney and their mitochondrial fractions following buthionine sulfoximine induced glutathione depletion in guinea pigs.
Seçkin S; Doğru-Abbasoğlu S; Başaran-Küçükgergin C; Yavu E; Cevikbaş U; Aykaç-Toker G; Uysal M
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):299-308. PubMed ID: 12889513
[TBL] [Abstract][Full Text] [Related]
51. Nephrotoxicity of thiazoles structurally related to thiabendazole in mice depleted of glutathione by treatment with buthionine sulfoximine.
Mizutani T; Yoshida K; Ito K
Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):29-38. PubMed ID: 1626124
[TBL] [Abstract][Full Text] [Related]
52. Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice.
Richie JP; Komninou D; Albino AP
Int J Oncol; 2007 Jun; 30(6):1539-43. PubMed ID: 17487376
[TBL] [Abstract][Full Text] [Related]
53. Gastric injury and protection against alcohol and acid: influence of perturbations in glutathione metabolism.
Smith GS; Tornwall MS; Barreto JC; Miller TA
J Surg Res; 1996 Mar; 61(2):395-403. PubMed ID: 8656615
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Andringa KK; Coleman MC; Aykin-Burns N; Hitchler MJ; Walsh SA; Domann FE; Spitz DR
Cancer Res; 2006 Feb; 66(3):1605-10. PubMed ID: 16452219
[TBL] [Abstract][Full Text] [Related]
55. Opposite action of S-adenosyl methionine and its metabolites on CYP2E1-mediated toxicity in pyrazole-induced rat hepatocytes and HepG2 E47 cells.
Wu D; Cederbaum AI
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G674-84. PubMed ID: 16306132
[TBL] [Abstract][Full Text] [Related]
56. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
Muldoon LL; Walker-Rosenfeld SL; Hale C; Purcell SE; Bennett LC; Neuwelt EA
J Pharmacol Exp Ther; 2001 Mar; 296(3):797-805. PubMed ID: 11181909
[TBL] [Abstract][Full Text] [Related]
57. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis.
Lopez SG; Luderer U
Free Radic Biol Med; 2004 Jun; 36(11):1366-77. PubMed ID: 15135172
[TBL] [Abstract][Full Text] [Related]
58. The influence of glutathione modulators on the course of Leishmania major infection in susceptible and resistant mice.
Cruz KK; Fonseca SG; Monteiro MC; Silva OS; Andrade VM; Cunha FQ; Romão PR
Parasite Immunol; 2008 Mar; 30(3):171-4. PubMed ID: 18251971
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction.
Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA
Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498
[TBL] [Abstract][Full Text] [Related]
60. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation.
Kang YJ
Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
